Iliyan Mihaylov1, Maciej Kańduła2,3, Milko Krachunov1, Dimitar Vassilev4. 1. Faculty of Mathematics and Informatics, Sofia University, "St. Kliment Ohridski", 5 James Bourchier Blvd., Sofia, 1164, Bulgaria. 2. Department of Biotechnology, Boku University, Vienna, 1180, Austria. 3. Institute for Machine Learning, Johannes Kepler University, Linz, 4040, Austria. 4. Faculty of Mathematics and Informatics, Sofia University, "St. Kliment Ohridski", 5 James Bourchier Blvd., Sofia, 1164, Bulgaria. dimitar.vassilev@fmi.uni-sofia.bg.
Abstract
BACKGROUND: Recently high-throughput technologies have been massively used alongside clinical tests to study various types of cancer. Data generated in such large-scale studies are heterogeneous, of different types and formats. With lack of effective integration strategies novel models are necessary for efficient and operative data integration, where both clinical and molecular information can be effectively joined for storage, access and ease of use. Such models, combined with machine learning methods for accurate prediction of survival time in cancer studies, can yield novel insights into disease development and lead to precise personalized therapies. RESULTS: We developed an approach for intelligent data integration of two cancer datasets (breast cancer and neuroblastoma) - provided in the CAMDA 2018 'Cancer Data Integration Challenge', and compared models for prediction of survival time. We developed a novel semantic network-based data integration framework that utilizes NoSQL databases, where we combined clinical and expression profile data, using both raw data records and external knowledge sources. Utilizing the integrated data we introduced Tumor Integrated Clinical Feature (TICF) - a new feature for accurate prediction of patient survival time. Finally, we applied and validated several machine learning models for survival time prediction. CONCLUSION: We developed a framework for semantic integration of clinical and omics data that can borrow information across multiple cancer studies. By linking data with external domain knowledge sources our approach facilitates enrichment of the studied data by discovery of internal relations. The proposed and validated machine learning models for survival time prediction yielded accurate results. REVIEWERS: This article was reviewed by Eran Elhaik, Wenzhong Xiao and Carlos Loucera.
BACKGROUND: Recently high-throughput technologies have been massively used alongside clinical tests to study various types of cancer. Data generated in such large-scale studies are heterogeneous, of different types and formats. With lack of effective integration strategies novel models are necessary for efficient and operative data integration, where both clinical and molecular information can be effectively joined for storage, access and ease of use. Such models, combined with machine learning methods for accurate prediction of survival time in cancer studies, can yield novel insights into disease development and lead to precise personalized therapies. RESULTS: We developed an approach for intelligent data integration of two cancer datasets (breast cancer and neuroblastoma) - provided in the CAMDA 2018 'Cancer Data Integration Challenge', and compared models for prediction of survival time. We developed a novel semantic network-based data integration framework that utilizes NoSQL databases, where we combined clinical and expression profile data, using both raw data records and external knowledge sources. Utilizing the integrated data we introduced Tumor Integrated Clinical Feature (TICF) - a new feature for accurate prediction of patient survival time. Finally, we applied and validated several machine learning models for survival time prediction. CONCLUSION: We developed a framework for semantic integration of clinical and omics data that can borrow information across multiple cancer studies. By linking data with external domain knowledge sources our approach facilitates enrichment of the studied data by discovery of internal relations. The proposed and validated machine learning models for survival time prediction yielded accurate results. REVIEWERS: This article was reviewed by Eran Elhaik, Wenzhong Xiao and Carlos Loucera.
Entities:
Keywords:
Breast cancer; Machine learning; Neuroblastoma; Semantic data integration; Survival time prediction
Authors: M Ashburner; C A Ball; J A Blake; D Botstein; H Butler; J M Cherry; A P Davis; K Dolinski; S S Dwight; J T Eppig; M A Harris; D P Hill; L Issel-Tarver; A Kasarskis; S Lewis; J C Matese; J E Richardson; M Ringwald; G M Rubin; G Sherlock Journal: Nat Genet Date: 2000-05 Impact factor: 38.330
Authors: Hansi Zhang; Yi Guo; Qian Li; Thomas J George; Elizabeth A Shenkman; Jiang Bian Journal: Proceedings (IEEE Int Conf Bioinformatics Biomed) Date: 2017-12-18
Authors: P Tarczy-Hornoch; T S Kwan-Gett; L Fouche; J Hoath; S Fuller; K N Ibrahim; D S Ketchell; J P LoGerfo; H I Goldberg Journal: Proc AMIA Annu Fall Symp Date: 1997
Authors: Adam A Margolin; Erhan Bilal; Erich Huang; Thea C Norman; Lars Ottestad; Brigham H Mecham; Ben Sauerwine; Michael R Kellen; Lara M Mangravite; Matthew D Furia; Hans Kristian Moen Vollan; Oscar M Rueda; Justin Guinney; Nicole A Deflaux; Bruce Hoff; Xavier Schildwachter; Hege G Russnes; Daehoon Park; Veronica O Vang; Tyler Pirtle; Lamia Youseff; Craig Citro; Christina Curtis; Vessela N Kristensen; Joseph Hellerstein; Stephen H Friend; Gustavo Stolovitzky; Samuel Aparicio; Carlos Caldas; Anne-Lise Børresen-Dale Journal: Sci Transl Med Date: 2013-04-17 Impact factor: 17.956
Authors: Wenqian Zhang; Ying Yu; Falk Hertwig; Jean Thierry-Mieg; Wenwei Zhang; Danielle Thierry-Mieg; Jian Wang; Cesare Furlanello; Viswanath Devanarayan; Jie Cheng; Youping Deng; Barbara Hero; Huixiao Hong; Meiwen Jia; Li Li; Simon M Lin; Yuri Nikolsky; André Oberthuer; Tao Qing; Zhenqiang Su; Ruth Volland; Charles Wang; May D Wang; Junmei Ai; Davide Albanese; Shahab Asgharzadeh; Smadar Avigad; Wenjun Bao; Marina Bessarabova; Murray H Brilliant; Benedikt Brors; Marco Chierici; Tzu-Ming Chu; Jibin Zhang; Richard G Grundy; Min Max He; Scott Hebbring; Howard L Kaufman; Samir Lababidi; Lee J Lancashire; Yan Li; Xin X Lu; Heng Luo; Xiwen Ma; Baitang Ning; Rosa Noguera; Martin Peifer; John H Phan; Frederik Roels; Carolina Rosswog; Susan Shao; Jie Shen; Jessica Theissen; Gian Paolo Tonini; Jo Vandesompele; Po-Yen Wu; Wenzhong Xiao; Joshua Xu; Weihong Xu; Jiekun Xuan; Yong Yang; Zhan Ye; Zirui Dong; Ke K Zhang; Ye Yin; Chen Zhao; Yuanting Zheng; Russell D Wolfinger; Tieliu Shi; Linda H Malkas; Frank Berthold; Jun Wang; Weida Tong; Leming Shi; Zhiyu Peng; Matthias Fischer Journal: Genome Biol Date: 2015-06-25 Impact factor: 13.583
Authors: Léon-Charles Tranchevent; Petr V Nazarov; Tony Kaoma; Georges P Schmartz; Arnaud Muller; Sang-Yoon Kim; Jagath C Rajapakse; Francisco Azuaje Journal: Biol Direct Date: 2018-06-07 Impact factor: 4.540